Pharmacist PrEP Coverage Expansion

Summary#

This bill (the "PrEP Access Act") would let Medicare Part B cover certain HIV prevention services when they are provided by pharmacists. The main change is to add “pharmacist‑provided HIV prevention services” to the list of covered services in the Social Security Act and to set how Medicare will pay for those services. The stated goal is to expand access to pre‑exposure prophylaxis (PrEP), post‑exposure prophylaxis (PEP), and related care by allowing pharmacists to bill Medicare for them.

• Main change: Adds a new category called “pharmacist‑provided HIV prevention services” that Medicare Part B can cover when pharmacists are legally allowed by state law to provide them.
• Services covered: Evaluation, management, screening, consultation, counseling, medication administration for PrEP/PEP or other evidence‑based HIV prevention, and related diagnostic laboratory tests.
• Payment rule: Medicare would pay 80% of the lesser of (a) the pharmacist’s actual charge or (b) 85% of the physician fee schedule amount for the same service.
• Balance‑billing rule: Pharmacists included in the relevant Medicare billing protections cannot bill beneficiaries above the Medicare‑approved amount.
• Limit and timing: Coverage would be limited to services that are “reasonable and necessary,” and the rule would start for services furnished on or after January 1, 2027.

What it means for you#

• Medicare beneficiaries

  • This could mean you may be able to get PrEP, PEP, counseling, and related tests from a pharmacist and have Medicare Part B pay for those services if the pharmacist is allowed to provide them by state law.
  • You could be protected from extra charges (balance bills) by pharmacists for these services that Medicare covers.
  • The bill does not change whether Medicare will pay for every pharmacist service — only those that are reasonable and necessary for HIV prevention.

• Pharmacists and pharmacies

  • Pharmacists who are allowed by state law to provide HIV prevention services could bill Medicare Part B for those services.
  • Payment to pharmacists would follow the special formula in the bill (see Payment rule above), which may be lower than physician payments.
  • Pharmacies may need new billing procedures and documentation to submit claims to Medicare.

• Doctors, clinics, and labs

  • Some services currently delivered in clinics (like PrEP counseling or lab tests) could be shifted to pharmacies if state law allows and billing arrangements are made.
  • Clinical coordination between pharmacists and other providers may be needed for ongoing care.

• State governments

  • The ability of pharmacists to provide these services depends on each state’s laws. If a state does not authorize pharmacists to perform these services, Medicare will not cover them from pharmacists in that state.

• Medicare program and taxpayers

  • The program would start processing claims for these pharmacist services and pay under the new formula. The overall budget impact is not stated in the bill.

Expenses#

No publicly available information.

• The bill text does not include a fiscal estimate or a congressional budget office score in the materials provided.
• This change could increase Medicare spending if more beneficiaries use covered pharmacist services. It could also shift where and how services are delivered.
• Administrative costs are likely for Medicare contractors, pharmacies, and providers to set up billing, claims processing, and oversight.
• The payment formula (80% of the lesser of the charge or 85% of the physician fee amount) may limit per‑service payments compared with standard physician payments.

Proponents' View#

• The bill appears intended to expand access to evidence‑based HIV prevention, such as PrEP and PEP, by allowing pharmacists to provide and bill Medicare for those services.
• Supporters may argue this could make prevention care more convenient and quicker to access, since many people can reach pharmacies more easily than clinics.
• Including pharmacists in the balance‑billing protections is designed to protect beneficiaries from surprise or extra charges.
• The bill targets medication administration, counseling, and related lab testing, which could allow pharmacists to deliver a more complete prevention service.

Opponents' View#

• One concern is variation in state law: the bill only covers services that pharmacists are legally authorized to provide in each state, so access gains could be uneven across the country.
• The payment formula may pay pharmacists less than physicians for the same service, which could affect pharmacy participation or the level of service offered.
• The bill does not provide a fiscal estimate; it is unclear how much Medicare spending would increase or what the long‑term budget impact would be.
• It is not detailed about how clinical oversight, care coordination, and follow‑up (for example, confirming lab results or managing side effects) would be handled when care shifts to pharmacists.
• Administrative and systems costs for billing, credentialing, and program integrity checks are not specified in the text.